Atea Pharmaceuticals
AVIR
AVIR
111 hedge funds and large institutions have $154M invested in Atea Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 33 increasing their positions, 39 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
15% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 39
19% less capital invested
Capital invested by funds: $190M → $154M (-$35.6M)
96% less call options, than puts
Call options by funds: $163K | Put options by funds: $3.67M
Holders
111
Holding in Top 10
1
Calls
$163K
Puts
$3.67M
Top Buyers
| 1 | +$907K | |
| 2 | +$841K | |
| 3 | +$591K | |
| 4 |
D.E. Shaw & Co
New York
|
+$490K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$406K |
Top Sellers
| 1 | -$1.6M | |
| 2 | -$607K | |
| 3 | -$516K | |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$394K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$333K |
